bay86-6150
Recombinant proteinexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT01921855)
Timeline
Indications
Mechanism of action
- Coagulation factor VIISupplementation
F7 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- bay86-6150
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01625390 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2012 | Bayer |
| NCT01921855 | Phase 1 | Jan 1, 2009 | Bayer |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 2 | 2 | 2 | 2009 |
1 organizations
Page 1 / 1